endo Flashcards
For patients with T2DM, HbA1c should be checked every 3-6 months until stable, then how often
6 monthly
What is the HbA1c target for patients with T2DM receiving management of lifestyle
48mmol/mol
6.5%
n.b. this is the same for those on metformin only
What is the HbA1c target for patients with T2DM receiving management of metformin
48mmol/mol
6.5%
n.b. this is the same for those on lifestyle only
What is the HbA1c target for patients with T2DM receiving management of any drug which may cause hypoglycaemia e.g. sulfonylureas
53mmol/mol
7.0%
What is the HbA1c target for patients with T2DM receiving management of any ONE drug, but now their HbA1c has risen to 58mmol/mol (7.5%)
53 mmol/mol
7.0%
This is the same for T2DM on sulfronyureas
Patients on ONLY metformin for T2DM (target = 48mmol/mol (6.5%), should only have a second diabetic drug added if the HbA1c rises to…
58mmol/mol
7.5%
First line drug in T2DM
Metformin
Second line drug in T2DM
After metformin established and uptitrated
(or if CVD, chronic heart failure, QRISK >10%)
SGLT-2 inhibitor
e.g. empaglifozin, canagliflozin, dapaglifozin
If metformin is contraindicated in T2DM, what medications can be given in a patient WITH risk of CVD, established CVD, or heart failure
SGLT-2 monotherapy
e.g. empaglifozin, canagliflozin, dapaglifozin
If metformin is contraindicated in T2DM, what medications can be given in a patient WITH risk of CVD, established CVD, or heart failure
SGLT-2 monotherapy
If metformin is contraindicated in T2DM, what medications can be given in a patient WITHOUT risk of CVD, established CVD, or heart failure
DPP-4 inhibitor (sitagliptin, linagliptin)
Or pioglitazone
Or sulfonylurea (gliclazide)
SGLT-2 may be used if certain NICE criteria are met.
Examples of DPP-4 inhibitors
GLIPTINS
linagliptin
sitagliptin
Examples of sulfonyureas
Glimepiride
Gliclazide
Glipizide
Tolbutamide
Examples of SGLT-2 inhibitors
empaglifozin
canagliflozin
dapaglifozin
Stepwise T2DM medications
- Metformin
- Add one of: DPP-4 inhibitors, pioglitazone, sulfonyurea, SGLT-inhibitor (if NICE criteria met of CVD/IHD/QRISK >10%)
- Add another from the list above OR start insulin treatment
- If triple therapy is not tolerated/effective then switch one for a GLP-1 mimetic if BMI >35 - specialist referral if on insulin too
If triple therapy for T2DM (metformin + two other drugs or addition of insulin) is not effective or tolerated, consider switching one of the drugs for…:
GLP-1 mimetic
e.g. liraglutide, dulaglutide, semaglutide
If triple therapy for T2DM (metformin + two other drugs or addition of insulin) is not effective or tolerated, consider switching one of the drugs for what class…?
GLP-1 mimetic
e.g. exenatide
Second-line therapy for T2DM if on metformin already, what can you add on
metformin + DPP-4 inhibitor
metformin + pioglitazone
metformin + sulfonylurea
metformin + SGLT-2 inhibitor (if NICE criteria met - CVD/IHD/QRISK >10%)
If metformin is not tolerated e.g. due to GI side effects, what should it be switched to
Metformin modified-release
If triple therapy for T2DM (metformin + two other drugs or addition of insulin) is not effective or tolerated, consider switching one of the drugs for GLP-1 mimetics. These can only be done for patients with:
BMI >35
BMI <35 but insulin havs occupational implications
Reduction of at least 11mmol/mol (1%) in HbA1c and weight loss of >3% in 6 months
When GLP-1 mimetics are added (after triple therapy for T2DM), can this be done in primary care
ONLY add GLP-1 mimetics to INSULIN in SPECIALIST care
When GLP-1 mimetics are added (after triple therapy for T2DM), can this be done in primary care
ONLY add GLP-1 mimetics to INSULIN in SPECIALIST care
NICE recommend starting with human NPH insulin - what type and when
Isophane, intermediate-acting
Bedtime or twice daily according to need
Blood pressure targets in T2DM
SAME as people without T2DM
<80 years: clinic 140/90, home 135/85
>80 years: clinic 150/90, home 145/85
Patients with subclinical hypothyroidism should have what treatment
normal T4/T3
high TSH 5.5-10
If <65 years, high TSH 5.5-10 on 2 separate occasions 3 months apart AND symptoms - consider 6 month trial of levothyroxine
If >80 years - watch and wait
Asymptomatic - watch and wait, repeat in 6 months
T1DM HbA1c should be monitored how often
Every 3-6 months
What is the T2DM HbA1c target
48mmol/mol (6.5%)
- same as T2DM
Blood glucose targets for T1DM:
(a) on waking
(b) before meals at other times of day
(a) on waking: 5-7
(b) before meals at other times of day: 4-7
When do NICE recommend adding metformin in T1DM
If BMI >25
for mealtime insulin replacement for adults with type 1 diabetes, what insulin should be offered
rapid-acting insulin ANALOGUES
injected before meals
(NOT rapid-acting soluble human or animal insulins)
what insulin should T2DM patients be started on
NPH insulin [aka isophane insulin] (injected once or twice daily according to need) should be offered
Kallman’s syndrome
What is high/low/normal for androgens
LH and FSH = low/normal
Testosterone = low
Klinefelter’s syndrome
What is high/low/normal for androgens
LH and FSH = high
Testosterone = low
Diabetes sick day rules
T1DM
How much fluid should be drank in one day
Encourage fluid intake at least 3 litres/day
Diabetes sick day rules
T1DM
How many times should blood sugars be checked, and insulin taken
Continue normal insulin regime but ensure checking blood sugars regularly (every 1-2 hours including night)
SGLT-2 inhibitors (dapagliflozin) has risks of which kind of infections
UTIs
Genital (candida)
Impaired fasting glucose (IFG)
Glucose levels and HbA1c levels
Glucose: 6.1-6.9 mmol/l
HbA1c: 42-47 mmol/mol (6-6.4%)
hyperthyroidism can lead to what bone disorder
osteoporosis
due to increased bone turnover from excess thyroid hormones
Type 2 diabetes
Glucose (fasting + 2 hours) and HbA1c levels
Fasting: 7.0 mmol/l
2 hours: >11.1 mmol/l
HbA1c: 48mmol/l (6.5%)
Patients with subclinical hypothyroidism should have what treatment if bloods show:
normal T4/T3
high TSH >10
levothyroxine if TSH >10 on 2 separate occasions 3 months apart
Normal/above average height
Delayed puberty
Hypogonadism
Anosmia
Low/normal LH/FSH
Low testosterone
what is the defect
Kallman’s syndrome
Klinefelter’s syndrome
what karyotype
47XXY
Patients with subclinical hypothyroidism (normal T4/T3, high TSH) should have what test
Thyroid peroxidase antibodies
Can indicate patients who can progress to hypothyroidism
Impaired glucose tolerance
Glucose levels at 2 hours
2 hours: 7.8-11.1 mmol/l
Diabetes sick day rules
T1DM
If struggling to eat, how can you maintain carb intake
Sugary drinks
When choosing between liraglutide (GLP-1 mimetic) vs orlistat (pancreatic lipase inhibitor) for obesity, which is preferential for patients with T2DM too?
Liraglutide (GLP-1 memetic)
n.b. BMI at least >35 and/or prediabetic hyperglycaemia (HbA1c 42-47) is criteria
Kallman’s syndrome - delayed puberty secondary to hypogonadotropic hypogonadism. What is its inheritance
X-linked recessive
Lack of smell (anosmia)
Delayed puberty
Inappropriately low/normal FSH and LH
Normal or above-average height
what is the condition
Kallman’s syndrome
Management of Kallman’s syndrome
What two things can be supplemented
- Testosterone
- Gonadotrophins - can result in sperm production if fertility is desired later on
Are patients with impaired glucose tolerance or impaired fasting glycaemia more likely to develop diabetes?
impaired glucose tolerance
What is the mechanism of action of SGLT-2 inhibitors (empagliflozin)
increasing urinary excretion of glucose
mechanism of action of sulphonylureas e.g. gliclazide.
Increase insulin release from pancreas
DPP4-inhibitors (GLIPTINS) e.g. sitagliptin, linagliptin, mechanism of action
reduce breakdown of incretins, decreases glucagon secretion from pancreas
Diabetic ketoacidosis criteria
Glucose >11
ketones >3
bicarb <15
pH is …?
pH <7.3
DKA is caused by uncontrolled…
LIPOLYSIS
leads to excess free fatty acids that convert to ketone bodies
3 most common precipitating factors of DKA
Infection
Missed insulin doses
Myocardial infarction
deep hyperventilation in DKA is called
Kaussmaul respiration
Diabetic ketoacidosis criteria
pH 7.3
Glucose >11
ketones >3
bicarb is …?
<15
Diabetic ketoacidosis criteria
bicarb <15
pH <7.3
Glucose >11
What are ketones?
ketones >3
Diabetic ketoacidosis criteria
bicarb <15
pH <7.3
Ketones >3 (or urine ++)
what is glucose?
Glucose >11
In DKA, fluids, insulin and K+ are given.
Insulin IV infusion should be started at what rate?
0.1unit/kg/hour
In DKA, fluids, insulin and K+ are given.
Insulin IV infusion is started at 0.1unit/kg/hour. When should dextrose be given?
When blood glucose reaches <14, 10% dextrose at 125mls/hr should be given along with 0.9% NaCl
Potassium infusions should not be given faster than…
20mmol/hour
What insulins should be stopped/continued during a patient’s DKA
Continue long-acting insulin
Stop short-acting insulin
Three criteria that define DKA resolution
pH >7.3
Ketones <0.6
Bicarb >15
When can patient’s with DKA be switched from IV to subcut insulin
When patient is eating and drinking
Addison’s disease (high ACTH, low cortisol, low aldosterone) leads to what electrolyte disturbance
Hyponatraemia
Hyperkalaemia
Aldosterone effects on Na/K levels
Retains (increases) Na+
Excretes K+
Hyperpigmentation is associated with one of the following - which one:
Primary’s hypoadrenalism - Addisons
Secondary adrenal insufficiency
Addison’s (primary hypoadrenalism)
Due to pituitary increased ACTH which breaks down into MSH and melatonin precursors
people with change in levothyroxine dose should recheck TFTs after how long
8-12 weeks
women who have hypothyroidism and then become pregnant should have levothyroxine dose changed by how much
increased by at least 25-50mcg of levothyroxine
levothyroxine can worse heart disease by which 2 side effects
worsens angina
atrial fibrillation
levothyroxine interacts with which 2 medications
iron and calcium carbonate
reduces the absorption of levothyroxine; give at least 4 hours apart
In type 1 diabetics, how many times should you aim to monitor blood glucose
at least 4 times a day
including before each meal and before bed